Consolidated Portfolio Review Corp: XLI position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Consolidated Portfolio Review Corp on XLI, newest first. How the timeline and the estimate are built.
Consolidated Portfolio Review Corp held 0 XLI shares at 2025-12-31 per its 13F-HR filed 2026-01-26.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -2,091 shares
13F-HR 0001754960-26-000118 filed by Consolidated Portfolio Review Corp
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 2,091 sharesChange vs previous 13F -392 shares
0.04% of the 13F portfolio, value $322,572.
13F-HR 0001754960-25-000777 filed by Consolidated Portfolio Review Corp
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 2,483 sharesChange vs previous 13F +252 shares
0.05% of the 13F portfolio, value $366,335.
13F-HR 0001754960-25-000433 filed by Consolidated Portfolio Review Corp
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 2,231 sharesChange vs previous 13F +639 shares
0.05% of the 13F portfolio, value $292,436.
13F-HR 0001754960-25-000239 filed by Consolidated Portfolio Review Corp
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 1,592 sharesChange vs previous 13F not available
0.03% of the 13F portfolio, value $209,762.
13F-HR 0001754960-25-000071 filed by Consolidated Portfolio Review Corp
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).